Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation

被引:460
|
作者
Pitson, SM
Moretti, PAB
Zebol, JR
Lynn, HE
Xia, P
Vadas, MA
Wattenberg, BW
机构
[1] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia
来源
EMBO JOURNAL | 2003年 / 22卷 / 20期
关键词
ERK; phosphorylation; sphingosine kinase; sphingosine; 1-phosphate; translocation;
D O I
10.1093/emboj/cdg540
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine kinase 1 is an agonist-activated signalling enzyme that catalyses the formation of sphingosine 1-phosphate, a lipid second messenger that has been implicated in a number of agonist-driven cellular responses, including stimulation of cell proliferation, inhibition of apoptosis and expression of inflammatory molecules. Although agonist-induced stimulation of sphingosine kinase activity is critical in a number of signalling pathways, nothing has been known of the molecular mechanism of this activation. Here we show that this activation results directly from phosphorylation of sphingosine kinase 1 at Ser225, and present several lines of evidence to show compellingly that the activating kinase is ERK1/2 or a close relative. Furthermore, we show that phosphorylation of sphingosine kinase 1 at Ser225 results not only in an increase in enzyme activity, but is also necessary for translocation of the enzyme from the cytosol to the plasma membrane. Thus, these studies have elucidated the mechanism of agonist-mediated sphingosine kinase activation, and represent a key finding in understanding the regulation of sphingosine kinase/sphingosine 1-phosphate-controlled signalling pathways.
引用
收藏
页码:5491 / 5500
页数:10
相关论文
共 50 条
  • [31] α-Tocopherol induces hematopoietic stem/progenitor cell expansion and ERK1/2-mediated differentiation
    Nogueira-Pedro, Amanda
    Barbosa, Christiano M. V.
    Comodo Segreto, Helena Regina
    Lungato, Lisandro
    D'Almeida, Vania
    Moraes, Andrea Aparecida F. S.
    Miranda, Antonio
    Paredes-Gamero, Edgar Julian
    Ferreira, Alice Teixeira
    JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 90 (06) : 1111 - 1117
  • [32] Molecular imaging of the kinetics of hyperactivated ERK1/2-mediated autophagy during acquirement of chemoresistance
    Aniketh Bishnu
    Pratham Phadte
    Ajit Dhadve
    Asmita Sakpal
    Bharat Rekhi
    Pritha Ray
    Cell Death & Disease, 12
  • [33] Unconventional EGF-induced ERK1/2-mediated Kv1.3 endocytosis
    Martinez-Marmol, Ramon
    Comes, Nuria
    Styrczewska, Katarzyna
    Perez-Verdaguer, Mireia
    Vicente, Ruben
    Pujadas, Lluis
    Soriano, Eduardo
    Sorkin, Alexander
    Felipe, Antonio
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (07) : 1515 - 1528
  • [34] IL-5-induced integrin adhesion of human eosinophils caused by ERK1/2-mediated activation of cPLA2
    Zhu, XD
    Jacobs, B
    Boetticher, E
    Myou, S
    Meliton, A
    Sano, H
    Lambertino, AT
    Muñoz, NM
    Leff, AR
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (05) : 1046 - 1053
  • [35] Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
    Munck, Joanne M.
    Berdini, Valerio
    Bevan, Luke D.
    Braithwaite, Hannah
    Buck, Ildiko M.
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James E.
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Hindley, Chris J.
    Kidane, Birikiti
    Kucia-Tran, Justyna
    Lyons, John F.
    Martins, Vanessa
    Muench, Sandra
    Murray, Chris W.
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David C.
    Rich, Sharna J.
    Richardson, Caroline J.
    Saini, Harpreet K.
    Shah, Alpesh
    Stanczuk, Lukas
    Thompson, Neil T.
    Walton, Hugh
    Wilsher, Nicola E.
    Woolford, Alison J.
    Wallis, Nicola G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [36] Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases
    Casar, Berta
    Rodriguez, Javier
    Gibor, Gilad
    Seger, Rony
    Crespo, Piero
    BIOCHEMICAL JOURNAL, 2012, 441 : 571 - 578
  • [37] BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation
    Yan, Y
    Spieker, RS
    Kim, M
    Stoeger, SM
    Cowan, KH
    ONCOGENE, 2005, 24 (20) : 3285 - 3296
  • [38] BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation
    Ying Yan
    Rebecca S Spieker
    Min Kim
    Scott M Stoeger
    Kenneth H Cowan
    Oncogene, 2005, 24 : 3285 - 3296
  • [39] ERK1/2, but not ERK5, is necessary and sufficient for phosphorylation and activation of c-Fos
    Gilley, Rebecca
    March, H. Nikki
    Cook, Simon J.
    CELLULAR SIGNALLING, 2009, 21 (06) : 969 - 977
  • [40] CaM kinase II-dependent activation of ERK1/2 in endothelium
    Borbiev, T
    Crow, M
    Garcia, JGN
    Verin, AD
    FASEB JOURNAL, 2003, 17 (05): : A1243 - A1243